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Nanotechnology has become the most advanced type of drug delivery system
within the last decade. This advancement shifted the focus on small carriers to increase
the efficiency of the drugs. Among these, gold nanoparticles (GNPs) were found to have
profound biomedical applications. In current research, kanamycin embedded GNPs were
prepared in a single step, single phase, and bio-friendly (green synthesis) procedure. The
synthesized Kanamycin-GNPs (Kan-GNPs) were spherical in shape and had a size range
of 15 ± 3 nm. The chosen kanamycin is an aminoglycosidic antibiotic that is isolated
from Streptomyces kanamyceticus. These special antibiotic GNPs are further
characterized using several analytical methods like Transmission Electron Microscopy
(TEM), Energy Dispersive Spectroscopy (EDS), Fourier Transform Infrared
Spectroscopy (FTIR), and Ultra-Voilet/Visible spectroscopy (UV/Vis spectroscopy). The
following research is a direct bio-friendly embedment of an antibiotic agent on the
surface of the GNPs without any secondary capping agent or surface modification
procedures.
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1. INTRODUCTION
1.1.

Bacteria
Bacteria are prokaryotes, simpler than any eukaryotic cell, but have more or less

similar features. The nucleic acid in an eukaryotic cell is similar to the plasmids in
bacteria. Bacteria have an extraordinary ability to transfer or exchange a gene which
makes them survive in extreme environments by developing resistance. The most
important structure of bacteria is the cell
wall whose composition and integrity
a
changes with change in species.(1) The
cell wall is made of carbohydrates called
peptidoglycan. Based on thickness of
b

the peptidoglycan in the cell wall and
their response towards crystal violet
dye, bacteria are divided into two types,
as gram positive and gram negative
bacteria.

(1)

Gram positive bacteria have

thick cell walls which show purple color

Fig. (1). (a) Cell wall with thick peptidoglycan
in gram-positive bacteria. (b). Cell wall with
negligible peptidoglycan layer in gram-negative
bacteria

when stained with crystal violet as
shown in Fig. (1a) where as gram negative bacteria have relatively thin cell walls as in
Fig. (1b) and do not retain purple color when stained with crystal violet.(2) These bacteria
have an ability to cause various diseases termed generally as bacterial infections.
Bacterial infections alone kill around 2 million people in the world.(3) They cause more
than 2000 hospitalizations and 60 deaths each year in the United States.(4) To treat these
bacterial infections, antibiotics are used. An antibiotic is a compound which either kills
1

the bacteria (bactericidal) or inhibits their growth (bacteriostatic).(5) Antibiotics targeting
specific species of bacteria are referred to as narrow-spectrum antibiotics where as
antibiotics that show a wide range of activity on different species are known as broad
spectrum antibiotics. Most of the bacteria developed resistance toward antibiotics due to
their repeated use.(6) Bacterial infections have been rapid once such resistant strains were
developed. Antibiotics, being the first line of defence, failed to kill bacteria reporting
multiple deaths.(7)
1.2.

Resistant bacteria
The bacterial resistance is an evolutionary technique adapted by bacteria to

survive extreme environments (like use of one or more antibiotics). Such resistant
bacteria are called Multi Drug Resistant (MDR) bacteria. For example, a β- Lactamase
producing strain of bacteria developed resistance towards β- Lactam antibiotics
(Pencillin).(8) Some other examples of species which were resistant to antibiotics are
Staphylococcus aureus for antibiotic named Methicillin and Enteroscoccus gallinarum
for antibiotic, Vancomycin.(9) Macrolides, licosamides, and steptogramins are other
examples of antibiotic classes for which both gram negative as well as gram positive
bacteria gained resistance. This resistance was achieved through a process called target
modification.(10) There is an increase in focus for the search of new drugs that overcome
these resistant strains.(9) Many efforts have been made to inhibit such bacteria, but
bacterial resistance is still a burning issue in chemotherapy of many bacterial
infections.(11) Thus a huge focus was shifted toward nanotechnology, a leading field of
science whose applications are widespread in fields like biological, biomedical,
pharmaceutical, catalytical, and optoelectronics.(8)

2

1.3.

Nanotechnology
New strategies have to be designed to treat resistant bacteria. Nanotechnology is

one approach that gained significance as a novel platform in treating bacterial resistance.
Nanotechnology is a field which deals with nanosized particles within a size range of 1 to
100 nm, and they are called nanoparticles.(12)
1.4.

Nanoparticles
Nanoparticles exist in different shapes and different sizes. Nanoparticles were

used to improve the efficiency of antibacterial agents or fight against MDR bacteria.
These nanoparticles are involved in antibacterial property by acting as drug carriers as
they can pass the biological membranes. They can be delivered in a controlled way such
that targeted drug delivery is achieved and help in concentrating the drug at a concerned
area.(13)
1.5.

Types of nanoparticles
Nanoparticles are classified based on their core material as inorganic and

organic.(14, 15) The nanoparticles with organic core are found to be toxic for human use
and they are also less stable at high temperature and pressure which causes problems
during formulation. Inorganic materials like metals and metal oxides have gained
importance in various fields and are more advantageous than organic materials in having
a long shelf life, stability and are also nontoxic to the human biological systems.(16, 17)
Inorganic core of nanoparticles are generally made of metals or metal oxides.(18) Metals
like silver, and gold are widely used as conventional inorganic core materials. Similarly,
metal oxides like zincoxide and titanium dioxide are used. Different types of
nanoparticles emerged, but were found to be toxic to the biological cell. Among them are
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silver, gold, zincoxide, and titanium dioxide, all of which gained importance in the field
of nanotechnology as they are less toxic and also posess diversified applications.(19)
1.6.

Zinc oxide nanoparticles (ZNPs)
Zinc oxide is an inorganic metal oxide which has a wide variety of applications in

many fields, especially in the field of pharmaceutics. ZNPs are widely used as an additive
in ceramics, glass, cement, rubber, lubricants, paints, ointments, adhesives, pigments,
foods, batteries, first aid tapes, etc.(20) Advantages of Zinc Nanoparticles (ZNPs) over
other nanoparticles are its high catalytic efficiency, chemical stability and strong
adsorption ability.(21)
The mechanism of action of ZNPs is still open. Some authors suggest that ZNPs
do not exhibit any antibacterial activity by themselves, but enhances the antibacterial
activity of certain antibiotics, (21) Other suggest that ZNPs as nanofluids, show a
significant antibacterial activity against E. coli.(16)
Disadvantage:
`

ZNPs are found to induce toxicity in the cells which leads to the production of

reactive oxygen species, oxidant injury, inflammation and finally the death of the cell.(22)
The zebra fish embryonic toxicity test was conducted using ZNPs, which killed the
embryos and thus was found to be toxic.(23)
1.7.

Titanium oxide nanoparticles (TNPs)
TNPs are not much used, but have a limited antibacterial activity. In their

preparation, TNPs have to be co-doped with another metal and a non-metal in which
silver and nitrogen are used respectively.(24) TNPs also carry the same toxic effects of
ZNPs besides antibacterial activity.(22)
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1.8.

Silver Nanoparticles (SNPs)
The antibacterial properties of silver are known from ancient times. Silver and its

ions are toxic to as many as 12 species of microorganisms.(25) Bacteria could not develop
resistance towards silver ions, which paved a path to focus on SNPs and their
antibacterial activity. SNPs are used in various applications like in dental work, on burn
wounds, etc.(26) SNPs are also used as sensors and biomarkers, but the main applications
of SNPs include its antibacterial use.(25)
The exact mechanism of action of SNPs is still unknown. The proposed
mechanism was that the SNPs would interact with the bacterial DNA and proteins there
by inhibiting their growth. The other possible mechanism of action was that SNPs might
disturb the respiratory chain in bacteria.(27) The SNPs might also be involved in physical
processes like disruption of the cell membrane, and could also penetrate into the cell and
leak the contents of bacteria. This effect is mainly observed in case of gram negative
bacteria.(25)
In the preparation of nanoparticles there must be a reducing agent to reduce the
crude form and then a capping agent to cap them and prevent them from aggregating.
Some of the reducing agents used to synthesise SNPs are gallic acid (28), ascorbic acid (29)
and citrates. The advantage of the citrate method over the other methods is that citrate
capped the nanoparticles besides reducing, thus acting as both a capping agent and a
reducing agent.(25)
Disadvantages:
Silver toxicity was discovered in 1983 by two scientists named Rungby and
Danscher by injecting SNPs in rats. The SNPs damaged the neural cells of the brain.
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They showed decrease in mitochondrial function in the liver cells, epidermal
keratinocytes and fibroblasts.(30) Extensive use of these SNPs became a bio-hazard in the
environment due to its toxicity. One example of such case was, SNPs toxicity towards
Chlamydomonas reinhardtii, an aquatic single celled organism.(27) SNPs are also known
for their toxicity and oxidative stress towards the human hepatoma cells.(31) SNPs were
also tested on zebra fish embryos which suggested that the SNPs inhibit the natural
development and also induce dose dependent toxicity.(32) SNPs are also believed to
damage the DNA and cause chromosomal aberrations in humans, leading to cell cycle
arrest.(33)
1.9.

Gold nanoparticels (GNPs)
Thus an alternate for the antibacterial activity showing nanoparticles were

required. Gold being abundant and naturally available showed some antibacterial activity
with much less toxicity. Among all nanoparticles, GNPs were found to be more stable
and effective.(34) The use of gold nanoparticles dates back to the 16th century.(35) Apart
from their antibacterial activity, GNPs were used in treatment of various diseases like
epilepsy, dysentery, tumors, in dental fillings and in the treatment of syphilis. (34) GNPs
were tested for their toxicity on human leukemia cells through exposure (a size range of
4-18 nm) for three days and the GNPs were found to be non-toxic to the leukemia
cells.(36) GNPs were also used for both medical and staining purposes. Gold nanoparticles
also have applications in analytical methods such as colorimetric techniques, which is
used to quantify heavy metal ions in aqueous solutions.(35)
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1.10.

Applications of GNPs
GNPs are used in various fields of biomedicine like biodistribution, photothermal

and photodynamic therapy, drug and gene delivery, immunology, bio-imaging, analytical
methods, and in various diagnostics.(37) GNP conjugates are also widely used as biolabels
in bioimaging for various biophotonic technologies, including dark-field resonance
scattering microscopy, confocal laser microscopy, diverse versions of two-photon
scattering, optical coherence and acoustic tomography.(37) In medical applications, gold
nanoparticles are used in treating B-chronic lymphocytic leukemia. The plasmon
resonances of GNPs were used in DNA detection. Conjugating with enzymes, GNPs help
in preparation of enzyme electrodes. Gold nanoparticles possess catalytic activity, hence
they are used for reactions such as the water-gas shift reaction and selective oxidation of
carbon oxide.(35)
GNPs are used in various advanced fields such as:
•

Biosensorics

•

Genomics

•

Clinical chemistry

•

Immunoassays

•

Immunresponse enhancement

•

Detection and control of microorganisms

•

Optical imaging of biological cells (including cancer cell imaging with resonance
scattering, optical coherence tomography, photoluminescence and photoacoustic
technique).

•

Cancer cell photothermolysis and
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•

Targeted drug delivery of drugs or genetic material and immunological
substances.
Along with the above applications, a huge focus was placed on delivery of the

drug using a nanoparticle based vector which helped in reducing toxicity to cell and
decresed the toxicity of the free drug.(38)
1.11.

Synthesis of GNPs
Different ways of synthesis were investigated. The main theme in synthesis of

GNPs in all of these process was to reduce colloidal solution using a reducing agent and
by capping it using a capping agent.
a. Preparation of GNPs with High temperature reduction: The preparation of
GNPs was achieved using high temperatures and also solvents, to reduce colloidal
gold. It can be performed in a single step, that is, the GNPs were formed with out
the help of capping agent, avoiding the capping step after the reduction. The
resulting GNPs were mono dispersive and were found to be stable during the
synthesis. Accelerated stability studies were performed, and it was observed that a
small amount of aggregation was seen at a temperature of 105 oC which would
also jeopardise the stability. Thus this process of producing GNPs using high
temperatures was not effective although the GNPs attained were
monodispersed.(39)
b. Preparation of GNPs using Ultra violet irradiation: In this method, GNPs were
synthesized using a low pressure mercury lamp and poly vinyl alcohol. The gold
colloidal solution was mixed with the poly vinyl alcohol and then exposed to the
lamp for 48 hours resulting in the production of GNPs with different shapes. No
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consistencey among the shapes were observed and it was also a time consuming
process.(40)
c. Preparation of GNPs using aspartate reduction of gold chloride: The
nanoparticles were prepared in an aqueous solution with the amino acid, aspartate,
which acts as a reducing agent of tetraaurochlorate.(41)
d. Preparation of GNPs using an amine: The preparations of GNPs were carried
out using a multifunctional amine, which acted both as a reducing as well as a
capping agent.(42)
Other methods include, the synthesis using citrate reduction of gold
colloidal solution, which is considered to be the standard in preparation of
GNPs.(36)
e. Biological methods: Not many, but few methods were developed where GNPs
were synthesized using biological organisms. One of them is synthesis using
Bacilius species.
f. Green synthesis: Even though the GNPs are biocompatible, chemical methods
used in their preparation can cause environmental hazards. To rule this out, a
process called green synthesis has evolved, where the preparation does not
include any hazardous chemicals. One such example of green synthesis of GNPs
is preparation using Cinnamomum Zeylanicum leaf broth.(43)
Disadvantage: All the green synthesis procedures are multiple step processes
which require a reducing agent as well as a capping agent, and they consume
more time and were less efficient.
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g. Preparation of GNPs using Citrate reduction: Among the conventional
methods of synthesis of GNPs, the most popular one has been the use of citrates
for reduction of colloidal gold in water. The citrate method rules out every
disadvantage that other methods have, but the GNPs prepared using the citrate
method were found to be carcinogenic.
In the current research, the method used was a novel, which has advantages such
as the synthesis of GNPs being done in a single step, single phase, and moreover it is a
green synthesis. No additional coating agents or reducing agents were used in this
process. In the green synthesis, the antibiotic used was kanamycin, which acts as both
capping and reducing agent. The GNPs were expected to improve the antibacterial
activity of kanamycin thereby ruling out resistance.
1.12.

Kanamycin
Kanamycin is a broad spectrum antibiotic, which is water soluble, insoluble in

alcohol, and weakly basic.(44) It shows antibacterial activity against both gram positive
and gram negative bacteria.(45) Studies reveal that, certain concentrations of kanamycin
are more bactericidal than bacteriostatic.(46)
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Fig. (2). Chemical structure of kanamycin showing its functional groups
Kanamycin belongs to the class of amino glycosides. It has a broad range of
antibacterial activity, that is, they act on both gram positive as well as gram negative
bacterial strains. Kanamycin was a potent antimicrobial agent until the bacterial strains
developed resistance towards it. The research was focused to overcome this resistance
using the nanoparticles, as they possess antibacterial activity and act as good inert carriers
of the drug. Nanoparticles were chosen because the bacteria could not develop resistance
towards them. The synthesis involved in this effort was a completely green procedure and
was performed in a single step. Kanamycin contains reducing functional groups for
which it was expected to reduce the gold colloidal solution to synthesize GNPs.
Kanamycin also acts as a capping agent to prevent aggregation of the GNPs. The whole
synthesis was carried out in an aqueous medium. Coating of kanamycin on the GNPs was
expected to show higher antibacterial activity than the regular antibiotic and was also
tested against both strains to evaluate the antibacterial activity.
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2. MATERIALS AND METHODS
2.1.

Materials
Potassium Aurochlorate (KAuCl4), Kanamycin Sulfate, Lysogeny Broth (LB)

agar, and Tryptic Soy (TS) agar were purchased from Aldrich, St. Louis, MO. The two
bacterial strains were obtained from the biological specimen collection at Western
Kentucky University.
2.2.

Synthesis of GNPs

Fig. (3). Synthetic scheme of kanamycin coated GNP
The main theme of the synthesis was to reduce Au3+ to Au0. GNPs were prepared
by reducing the KAuCl4 using kanamycin (single step) in an aqueous medium (single
phase). This process of synthesis did not require any coating agent, as kanamycin acts as
both reducing as well as capping agent. The gold colloidal solution of 300 ppm
concentration was mixed with aqueous kanamycin solution of 1mg/ml concentration in
an aqueous medium and incubated for 12 hours at 150 rpm and at a temperature of 37 ºC
(47)

. The formation of GNPs was confirmed by the color change from colorless to light

pink. The obtained GNPs were centrifuged at 15,000 rpm for 15 minutes, which make the
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NPs settle at the bottom. These settled nanoparticles were resuspended in nano pure water
and centrifuged again. This washing process was repeated several times so that the free
kanamycin or colloidal gold solution is no longer present. They were further processed
using nanopure water and used for analysis.(47)
2.3.

Characterization of Kan-GNPs
The Kan-GNPs formed were characterized using various anaytical instruments. A

Transmission Electron Microscope (TEM) was used to determine the shape and size of
the nanoparticles. 400 mesh size copper grids were used in the imaging. The grids were
washed with hydrochloric acid, water and acetone and allowed to sit for drying. These
washed grids were coated with firmvar. Approximately 5 µL of Kan-GNP solution was
added to the grid and then viewed under the microscope.(47)
To determine the interactions between the capping agent and nanoparticle’s
surface, a Perkin Elmer Spectrum 100-Fourier Transform Infrared Spectroscopy (FTIR)
was used. The blank used was kanamycin powder. The Kan-GNP solution was
concentrated by removing the extra suprenatent liquid and dried in the ependorf using a
heating pan. The characterized nanoparticles were further analysed for their antibacterial
activity.
2.4.

Antibacterial activity
The efficiency of the synthesized nanoparticles was determined using

antibacterial experiments. In all the antibacterial experiments performed, a bacterial
culture prepared from 100 µL glycerol stock in 10 ml of fresh autoclaved medium was
used. The antibacterial activity was tested against two strains representing two different
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classes, Escherichia coli (gram negative) and Staphylococcus epidermidis (gram
positive).
a. Turbidimetry
Turbidimetry is a method, in which the effect of antibiotics or other drugs is
measured in a liquid media by using a photoelectric colorimeter. It is a process of
measuring loss of intensity of transmitted light due to scattering effect of particles
suspended in the sample. Turbidimetry is one of the two optical methods, the other one
being Microdilution (Plate count), used to determine the minimum inhibitory
concentration (MIC).(48) MIC is the concentration of an antibacterial agent required to
inhibit growth of bacterial cultures. In the field of biology, turbidimetry is also used to
find the number of cells in a solution. The data from turbidity measurements were used to
construct growth curves. In this process different concentrations of Kan-GNPs were
treated with constant amount of bacteria in sterile liquid medium and incubated for 12
hours at 37 ºC. With a time interval of an hour, the bacteria were quantified by measuring
their optical density (OD) at 600 nm using a Spectronic-20 instrument. The OD of
bacterial cultures in the absence of Kan-GNPs was also determined, which acts as a
control.
b. Spread plate technique
Spread plate technique is a biological experiment, where the viable bacteria are
measured in accordance with the concentration of antimicrobial agent applied.(49) In this
method, the sterile nutrient agar medium was prepared and allowed to solidify on a petri
dish, later the bacterial suspension was spread over the solidified agar medium with the
aid of a sterile spreader. (8) The petri dish was allowed to incubate at the appropriate
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temperature for a certain time and then observed for the bacterial colonies. The two
bacterial strains (E. coli, S. epidermidis) were treated with different concentrations of
Kan-GNPs and spread on a solid agar growth medium and incubated at 37 ºC for 12
hours. The bacteria start to form colonies which are visible. This helps in the
determination of viable bacteria with different doses of Kan-GNPs. The number of
colony forming units was counted using a flow cytometer.
c. Agar well diffusion method
Agar diffusion techniques have been widely used in microbiological assays. In
this method, the antibiotic present in the agar wells, diffuses into the pre-inoculated
solidified agar medium, thereby inhibiting the growth of the microorganisms.(49) By using
a cork borer, wells of size ranging from 6 mm - 8 mm were aseptically punched by
maintaining at least 30 mm distance between adjacent wells. The fixed amount of test
solution (antibiotic, plant extract) was poured into the wells and incubated for 24 hours at
37 ºC. In this experiment, the wells were filled with traditional antibiotic (kanamycin
stock solution) which is used as control, as well as the Kan-GNPs. The zone of inhibition
was determined. This provides the potency of the nanoparticles in comparison with the
antibiotic.
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3. RESULTS
3.1.

Synthesis of Kan-GNP
Gold colloidal solution is easily reduced from Au3+ to Au0 to form gold

nanoparticles, but has to be capped to avoid aggregation. Thus a reducing agent as well as
a capping agent were required. In major synthetic procedures, use of different reducing
agents and capping agents were shown but none of them were found effective due to their
respective disadvantages.(39 - 43) Kanamycin contains reducing functional groups along
with 7-hydroxyl groups and was used in the research expecting to reduce the colloidal
gold solution in an aqueous medium. To determine the exact concentration of gold
solution and kanamycin to form the desired Kan-GNP, different trials were performed by
keeping the concentration of kanamycin constant at 1 mg/ml and by varying the
concentration of the gold solution as shown in table 1. The reduction process was carried
out in test tubes and incubated these test tubes for 12 hours in an incubator at 37 ºC. The
change of color from colorless to dark pink/purple was indicative of successful reduction
of gold colloidal solution.(54) As the concentration of gold increased from 100 ppm to 600
ppm, the intensity of the color increased as shown in Fig. (4). The increase in the
intensity of color was expected to be a representation of excessive reduction. Among all
the concentrations tried, the 300 ppm of gold solution showed promising color with 1
mg/ml kanamycin concentration. Similar trials were performed with constant
concentration of gold solution at 300 ppm and varying the kanamycin concentration as in
table 2. In these trails, as the concentration of kanamycin stock was changed, the color
decreased in intensity as shown in Fig. (5), and this is due to the insufficient gold
colloidal solution to reduce by the kanamycin. 1 mg/ml concentration of kanamycin
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showed a promising color. These derivations from the synthesis were confirmed by
further characterization of Kan-GNPs.
3.2.

Characterization of Kan-GNPs
Kan-GNPs formed at 300 ppm and 1 mg/ml were chosen. The sample was washed

several times to eliminate the excess kanamycin or unreduced gold colloidal solution.
This was achieved by taking the sample in small volumes and diluting it with nanopure
water and centrifuged at a speed of 15000 rpm until the Kan-GNPs settled at the bottom.
The supernatant solution was removed using a pipette without disturbing the pellet. This
pellet was again resuspended in nanopure water. The washing process was repeated
several times. Washing the sample several times was considered important as the
impurities might interfere with the results.
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Concentration of gold

Colour observed

Formation of nanoparticles

100 ppm

Light pink

Low in number

200 ppm

Light pink

Resaonable

300 ppm

Pink

Very good

400 ppm

Pink

Clusters

500 ppm

Dark pink

Clusters

600 ppm

Dark pink

Clusters

Table 1. Gold dependent Kan-GNP synthesis showing formation of nanoparticles using
different concentrations of gold ranging from 100 ppm to 600 ppm prepared from gold
colloidal stock solution, which suggests that the 300 ppm gold concentration yielded
good number and desirable form of nanoparticles.

Fig. (4). Test tube pictures of Kan-GNP to show the color change indicating the
reduction reaction. These are prepared with different concentrations of gold and
concentration of 1mg/ml of kanamycin.
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Concentration of Kanamycin Colour observed

Formation of nanoparticles

0.25 mg/ml

Pink

Cluster

0.5 mg/ml

Pink

Good

1 mg/ml

Pink

Very good

2 mg/ml

Pink

Good

3 mg/ml

Light Pink

Low in number

4 mg/ml

No colour change No formation of GNPs

Table 2. Kanamycin dependent Kan-GNP synthesis showing formation of
nanoparticles using different concentrations of kanamycin ranging from 0.25
mg/ml to 4 mg/ml prepared from the kanamycin stock solution, which suggest
that the 1mg/ml kanamycin concentration yielded a good number and
desirable form of nanoparticles

Fig. (5). Test tube pictures of Kan-GNPs to show the color change indicating the
reduction reaction. These are prepared with different concentrations of kanamycin and
concentration of 300 ppm of gold
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3.3.

Transmission Electron Microscopy (TEM)
TEM is an analytical instrument in which the sample is treated with a high

intensity electron beam in a vaccum. The scattering of this high intensity beam gives a
dark image on the microfilm, which can be photographed. The resolution of a TEM is
higher than a conventional microscope, which is in the nano range. TEM helps in
providing the shape and size of the nanoparticles. To view a sample in TEM, a copper
grid is used, which is thoroughly cleaned and coated with firmvar. Different samples of
Kan-GNPs mentioned in the trials were viewed under TEM which revealed the
morphological character of nanoparticles. The TEM results in Fig. (6) suggest that the
nanoparticles are monodispersed and have a unique size at a concentration of 300 ppm
gold stock solution and the TEM results in Fig. (7) indicate that the 1mg/ml concentration
of kanamycin gave desirable results. The other images show either a low number of
nanoparticles or of clusters. These pictures confirm the hypothesis made during the
synthesis. The TEM results also suggest that the shape of the nanoparticles was ranging
approximately 15 ± 3 nm.
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Fig. (6). To confirm the reduction and to determine the size of the nanoparticles, TEM
imaging is done. From the above data 300 ppm of gold concentration showed consistent
shape and a good number of nanoparticles and the size range was found to be 15 ± 3 nm.

Fig. (7). To confirm the formation of nanoparticles and to determine the size of the
nanoparticles, TEM imaging is performed. From the above data 1mg/ml
concentration of kanamycin showed consistent shape and a good number of
nanoparticles and the size range was found to be 15 ± 3 nm.

21

3.4.

UV/Vis spectroscopy
The UV/Vis spectroscopy is a widely used analytical technique to determine the

intensity of light either transmitted or absorbed. The absorbance of the light or the
scattering of the light depends on the physical properties of the sample. Nanoparticles
exhibit peaks at specific wavelengths due to their surface plasmon resonance.(55) This
scattering of the light in SPR band depends on the size of the nanoparticle and also their
dispersion in the medium. The UV/Vis spectroscopy of Kan-GNP yielded a peak at
approximately 550 nm as shown in Fig. (8a), which indicates that the peak was within the
range of the SPR band. This helps in confirmation that the Kan-GNPs were in the size
range of about 15 ± 3 nm and also exist in spherical shape.
3.5.

SEM-EDS analysis
SEM is an analytical instrument which helps in providing 3-D images. SEM can

be fused to a high energy X- Ray emitting device termed EDS. These X-rays help in
determination of presence, amount, and distribution of elements in the sample.The
principle involved in EDS is when the sample is bombarded with high energy X-ray
beam, they excite and provide a peak. These peaks are confined to particular elements,
which provide the elementary composition of the sample. The copper grid with Kan-GNP
was placed on an aluminum stab and viewed under SEM/EDS spectroscopy. As expected,
the reduced gold concentration was found to be 86.34 w% and other elements include
6.52 w% of oxygen and 7.14 w% of carbon as shown in Fig. (8c).

22

Fig. (8). (a) UV/Visible spectrum of Kan-GNP with a broad peak at approximately 550
nm. This indicates that it is a heterogenous compound and also suggests that the
nanoparticles formed were coated effectively.(b) TEM image of Kan-GNP which was
synthesized using 1mg/ml kanamycin stock solution and 300 ppm gold concentration.
The size of the nanoparticles was approximately found to be 15 ± 3 nm. (c) The SEM
image along with the dispersion spectrum of the Kan-GNPs. This showed 86.34 w% of
gold, 6.52 w% of oxygen and 7.14 w% of carbon.
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3.6.

FTIR spectroscopy
Every functional group exists in its own vibrational mode. These vibrations are

sensitive toward any change in the functional group. This provides the information of
interaction between two elements. FTIR was performed on the Kan-GNPs to determine
the interactions between kanamycin and GNPs. The spectrum showed a shift between
2833.54 cm-1 to 3115.51 cm-1 as shown in Fig. (9), which is a typical stretch for a
hydroxyl functional group, indicating the involvement of hydroxy groups in bonding of
kanamycin with the nanoparticles. Other minor stretchings were also found between
2117.0 cm-1 to 2120.79 cm-1 and 1591.0 cm-1 to 1608.95 cm-1 indicating the involvement
of triple bond carbon and carboxyl group respectively.
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Fig. (9). FTIR spectrum of a) Kan-GNP and b) control kanamycin stock reveals a stretch
at 2833.54 cm-1 to 3115.51 cm-1, a typical stretch for a hydroxyl group indicating the
involvement of hydroxy groups in bonding with the nanoparticles. Other minor
stretchings were also found at 2117.0 cm-1 to 2120.79 cm-1 and 1591.0 cm-1 to 1608.95
cm-1 indicating the involvement of triple bond carbon and carboxyl group respectively.
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3.7.

Antibacterial activity of Kan-GNPs tested against E. coli

3.7.1. Turbidimetry
Turbidimetry is a biological process of quantifying the bacterial growth. It is a
measurement of scattering of light due to the bacteria present in a suspension. More the
bacteria, more light will be scattered, indicating increased growth and vice versa. The
light scattering was observed at 600 nm. Turbidimetry also provides the information of
MIC. The turbidity of the E. coli was measured in a liquid medium. The bacterial culture
treated with different concentrations of Kan-GNPs and a culture with no Kan-GNP
(control), were incubated for 12 hours. The optical density was measured at 600 nm for
every hour and the results were plotted in a graph. They suggest that, as the concentration
of the Kan-GNPs increased, the growth of the cells declined as shown in Fig. (10). The
MIC was found to be approximately 0.15 mg/ml where no growth of the bacteria was
observed.
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Fig. (10). The growth curve of E. coli treated with different concentrations of
Kan-GNP. The concentrations used were 0 mg/ml (control), 0.02 mg/ml, 0.04
mg/ml, 0.06 mg/ml, 0.08 mg/ml, 0.1 mg/ml, and 0.15 mg/ml. Among them the
minimum inhibitory concentration (MIC) was found to be 0.15mg/ml.
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3.7.2. Spread plate assay
Spread plate technique is the measurement of surviving bacteria after treating the
bacterial culture with specific antibiotics. The bacterial cultures in liquid medium with
varying concentrations of Kan-GNPs were spread on a solid agar well with an autoclaved
spreader. A control was also made in which bacterial culture without the treatment of
Kan-GNP was spread on the agar plate. The results after the incubation of 12 hours
suggest that the Kan-GNP was more effective and showed a dose dependent action on E.
coli as shown in the Fig. (11a). The graphs relative to the spread plate assay was plotted
with number of colonies on the Y- axis and concentration of Kan-GNPs on the X- axis as
shown in Fig. (11b). This suggests that the MIC found in the turbidity measurements
were in total agreement with that of the spread plate assay.
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Fig. (11). (a) Spread plate assay performed on E. coli strain by treating the strain with
different concentrations of Kan-GNPs. The control is non treated bacterial strain
exhibiting a large number of colonies which decreased as the concentration of KanGNP was increased. (b) A histogram of the spread plate assay which shows a dramatic
decline in the growth of the bacteria from approximately 300 colonies in the control to 0
in 0.12 mg/ml.
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3.7.3. Agar well diffusion assay
The agar well diffusion method determines the potency of the Kan-GNPs in
comparison to the control (kanamycin stock). Similar to the disk diffusion assay, agar
well diffusion assay was performed, in which the bacterial preculture grown in agar
medium was treated with different concentrations of Kan-GNPs in the bores. This
provides a zone of inhibition of growth that is, the extent of antibacterial agent diffusing
across a solid agar to kill bacteria. The larger the zone of inhibition the more potent it
would be. The petri plates were incubated for 12 hours and the radius of the zone of
inhibition was measured. For E. coli with Kan-GNP, the zone of inhibition was found
maximum of approximately 0.6 cm at 0.24 mg/ml as shown in Fig. (12a). The graphs
relative to the agar well diffusion assay was plotted with the radius of the zones on theYaxis and concentration of Kan-GNPs on the X- axis as in Fig. (12b). A similar
experiment was performed with kanamycin alone as a control as in Fig. (13a), in which
the zone of inhibition was maximum at 1.5 mg/ml. The comparative result suggests that
the Kan-GNPs were more effective at a lower concentration than the kanamycin control
to attain similar antibacterial activity.
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Fig. (12). (a) Agar well diffusion assay performed on E. coli strain by treating the
strain with different concentrations of Kan-GNPs in a bore across the solid agar. The
radius of the zone around the well was measured and found maximum at 0.24
mg/ml. (b) A histogram of the agar well diffusion assay with Kan-GNP which
shows a dramatic increase in the radius of the zone with a maximum radius of
approximately 0.6 cm at 0.24 mg/ml.
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Fig. (13). (a) Agar well diffusion assay performed on E. coli strain by treating the
strain with different concentrations of kanamycin in a bore across the solid agar.
The radius of the zone around the well was measured and found maximum at 1.5
mg/ml. (b) A histogram of the agar well diffusion assay with kanamycin which
shows an increase in the radius of the zone with a maximum radius of
approximately 0.8 cm at 1.5 mg/ml.
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3.8.

Antibacterial activity of Kan-GNPs tested against S. epidermidis
3.8.1. Turbidimetry
The turbidimetric measurements of S. epidermidis showed similar results as that

od E. coli. When the concentration of the Kan-GNP was increased, the growth of the
bacteria declined, which is represented in the growth curve in Fig. (14). The MIC was
found to be 0.08 mg/ml.
3.8.2. Spread plate assay
The spread plate assay of S. epidermidis reveals that, the control has around 300
colonies of bacteria, and 0.06 mg/ml treated agar well showed no colonies, which is
shown in Fig. (15a). The results were depicted in a histogram with number of colonies on
the Y- axis and concentration of Kan-GNP on the X- axis Fig. (15b).
3.8.3. Agar well diffusion assay
In the agar well diffusion assay of S. epidermidis with Kan-GNP, the zone of
inhibition was maximum at approximately 0.6 cm at 0.24 mg/ml as shown in Fig. (16a).
The graphs relative to the diffusion assay was plotted with the radius of the zones on the
Y- axis and concentration of Kan-GNPs on the X- axis, shown in Fig. (16b). A similar
experiment was performed with kanamycin alone as a control, shown in Fig. (17a &
17b), in which the zone of inhibition was maximum at 1.5 mg/ml. The above result
suggests that, the Kan-GNPs were more effective than the kanamycin (control).
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Fig. (14). The growth curve of S. epidermidis treated with different concentrations
of Kan-GNP. The concentrations used are 0 mg/ml (control), 0.02 mg/ml, 0.03
mg/ml, 0.04 mg/ml, 0.05 mg/ml, 0.6 mg/ml, and 0.08 mg/ml. Among them the
minimum inhibitory concentration (MIC) was found to be 0.08 mg/ml.
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Fig. (15). (a) Spread plate assay performed on S. epidermidis strain by
treating the strain with different concentrations of Kan-GNPs. The control is
non treated bacterial strain exhibiting a large number of colonies which
decreased as the concentration of Kan- GNP was increased. (b) A histogram
of the spread plate assay which shows a dramatic decline in the growth of the
bacteria from approximately 280 colonies in the control to 0 in 0.06 mg/ml.
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Fig. (16). (a) Agar well diffusion assay performed on S. epidermidis strain by
treating the strain with different concentrations of Kan-GNPs in a bore across
the solid agar. The radius of the zone around the well was measured and found
maximum at 0.24 mg/ml.(b) A histogram of the agar well diffusion assay with
Kan-GNP which shows a dramatic increase in the radius of the zone with a
maximum radius of approximately 0.6 cm at 0.24 mg/ml.
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Fig. (17). (a) Agar well diffusion assay performed on S. epidermidis strain
by treating the strain with different concentrations of kanamycin in a bore
across the solid agar. The radius of the zone around the well was measured
and found maximum at 1.5 mg/ml. (b) A histogram of the agar well
diffusion assay with kanamycin which shows an increase in the radius of
the zone with a maximum radius of approximately 0.8 cm at 1.5 mg/ml.
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4. DISCUSSION
Increase in focus towards the nanoparticles was due to the development of multi
drug resistant strains. Kanamycin was found to be more potent and effective until bacteria
developed resistance against it.(7) Among different types of nanoparticles, GNPs were
found to be effective and non toxic. It was a challenge to synthesize environmental
friendly GNPs, which was overcome by the green synthesis. The focus of the research
was to counter the resistance with new techniques in a bio-friendly manner. The main
theme of the synthesis was to reduce colloidal gold using kanamycin in a single phase,
single step and in bio-friendly process. Kanamycin helps in both reduction as well as
capping of the nanoparticles. The formation of Kan-GNPs was noticed by the color
change from colorless to pink/purple.
The nanoparticles were characterized using various techniques. A TEM was used
to determine the morphological characters, i.e., the TEM images provide the size and
shape of the nanoparticles. The nanoparticles synthesized were found to be in the range
of 15 ± 3 nm and were also found to be resuspendable without any clusters. The UV/Vis
spectroscopy was performed to determine the optical properties of the nanoparticles. The
Kan-GNP yielded a spectrum with a peak around 550 nm wavelength which was a
characteristic peak for GNPs in SPR band. The FTIR was performed to find the
interactions between the nanoparticles and a coating agent, which revealed that, the bond
between them is due to the interaction of hydroxyl group of Kanamycin with GNP. This
interaction was confirmed by observing a stretch in the hydroxyl region in FTIR
spectrum which was compared to that of the control’s spectrum. The SEM-EDS data
reveals more insight towards the elemental compostion of the Kan-GNPs. The peaks
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were relative to gold even after several washings, indicating the generated GNP is the
result of reduced colloidal solution of gold. The elemental percentage was found to be
86.34 w% of gold, 6.52 w% of oxygen and 7.14 w% of carbon.
The antibacterial effects were tested against two strains: gram positive and gram
negative bacteria. Turbidity measurements were performed by incubating liquid agar
cultures of the strains and by measuring the optical density at 600 nm. Thus MIC values
were calculated for both the strains from turbidity measurements. For E. coli the MIC
was found to be 0.15 mg/ml and for S. epidermidis the MIC was found to be 0.08 mg/ml.
These values suggest that the Kan-GNPs exhibit bacteriostatic effect.
Spread plate assays were performed to evaluate the bactericidal effect of KanGNP and by comparing it with the kanamycin control. The assays showed a great
difference in the number of colonies for Kan-GNP, when compared to that of kanamycin
control for both the strains. The number of colonies decreased dramatically as the
concentration of the Kan-GNP was increased for both the strains. This indicates that the
Kan-GNPs were more potent than the control kanamycin.
Agar well diffusion was also performed, in which the zone of inhibition was
calculated after treating solid culture medium with different concentrations of Kan-GNPs
and also by comparing them with kanamycin. The radius of the zone of inhibition for
Kan-GNP treated E. coli was found to be 0.6 cm at 0.24 mg/ml, whereas the control
showed the same radius at around 1.2 mg/ml. Similarly the radius of the zone of
inhibition for Kan-GNP treated S. epidermidis was found to be 0.6 cm at 0.24 mg/ml,
where as the control showed the same radius at around 1.2 mg/ml. The results of agar
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well diffusion assay reveal that the Kan-GNP was found to be more effective than the
traditional antibiotic.
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5. CONCLUSION
GNPs were successfully synthesized by a simple procedure, in a single step,
single phase, bio-friendly manner, and were efficiently coated with kanamycin. The
synthesized nanoparticles were well characterized using various techniques, which
confirmed that the Kan-GNPs were stable. They exist in the size range of 15 ± 3 nm. The
hydroxyl groups of kanamycin were found to interact with the GNPs, which not only
reduces the NPs but caps them as well.
The antibacterial experiments were conducted on E. coli (gram negative bacteria)
and S. epidermidis (gram positive bacteria). The MIC was determined for both the
strains. The MIC for S. epidermidis was found to be 0.08 mg/ml and for E. coli was 0.15
mg/ml. Thus Kan-GNPs were found to be more effective in treating gram positive
bacteria than the gram negative bacteria. The difference in the effectiveness is accounted
for the difference in the cell wall thickness. The results suggest that, unlike the traditional
antibiotic, kanamycin, Kan-GNPs showed enhanced antibacterial activity on both the
strains.

41

REFERENCES

1.

Salton, M. R. J. Studies of the bacterial cell wall: IV. The composition of the cell
walls of some gram-positive and gram-negative bacteria. 1953, 10, 512-523.

2.

Madigan, M.; Martinko, J. Brock Biology of Microorganisms, 11th ed.; Prentice Hall,
2005.

3. Whitman, W. B.; Coleman, D. C.; Wiebe, W. J. Prokaryotes: the unseen majority.
Proceedings of the National Academy of Sciences of the United States of America 95.
1998, 6578–83.
4. Ronnie, L. P.; Oscar, R. M.; Chang-Cheng, Y.; Vincent, M. R.; Uwe, H. F. B. Rapid
and Efficient Identification of Bacteria Using Gold-Nanoparticle–Poly(paraphenyleneethynylene). Angew. Chem. Int. Ed. 2008, 47, 2590-2594.
5. Walksman, S. A. What Is an Antibiotic or an Antibiotic Substance? Mycologia. 1947,
39, 565–569.
6. Wright, G. D. Antibiotic resistance in the environment: a link to the clinic. J of M. I.
B. 2010, 13, 589–94.
7.

Owen, J. Antibiotics losing the fight against deadly bacteria. The Independent. 2011,
p 2.

8.

Akhilesh, R.; Asmita, P.; Carole, C. P. Antibiotic Mediated Synhtesis of Gold
Nanoparticles with potent antimicrobial activity and their applications in
antimicrobial coatings. Journal of Material Chemistry. 2010, 6789-6798.

9. Yarnell, A. Kicking Out Drug Resistance. Chemical & Engineering News Archive.
2004, 82,

42

10. Roberts, M. Environmental macrolide–lincosamide–streptogramin and tetracycline
resistant bacteria. Frontiers in Microbiology. 2011, 2, 40.
11. Bennett, P. M. Plasmid encoded antibiotic resistance: Acquisition, and transfer of
antibiotic resistance genes in bacteria. J Pharmacol. 2008, 153, S347–S357.
12. Virender, K. S.; Ria, A. Y.;Yekaterina, L. Silver nanoparticles: Green synthesis and
their antimicrobial activities. Elsevier. 2009, 145, 83-96.
13. Yuyun, Z.; Yue, T.; Yan, C.;Wenwen, L.; Wanshun, M.; Xingyu, J. Small MoleculeCapped Gold Nanoparticles as Potent Antibacterial Agents That Target GramNegative Bacteria. J. Am. Chem. Soc. 2010, 132, 12349–12356 9.
14. Zhang, L., et al. Investigation into the antibacterial behaviour of suspensions of ZnO
nanoparticles (ZnO nanofluids). Journal of Nanoparticle Research. 2007, 9, 479–489.
15. Raghupathi, K. R.; Koodali, T. R.; Manna, A. C. Size Dependent Bacterial Growth
Inhibition an Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles.
Langumir. 2011, dx.doi.org/10.1021/la 104825u.
16. Zhang, L., et al. Investigation into the antibacterial behaviour of suspensions of ZnO
nanoparticles (ZnO nanofluids). Journal of Nanoparticle Research. 2007, 9, 479–489.
17. Raghupathi, K. R.; Koodali, T. R.; Manna, A. C. Size Dependent Bacterial Growth
Inhibition an Mechanism of Antibacterial Activity of Zinc Oxide Nanoparticles.
Langumir. 2011, dx.doi.org/10.1021/la 104825u.
18. Monty, L.;Jie, L.; Michael, K.; Tian, X.; Stefan, G. R.; Andre, E. N.; Fuyuhiko, T.;
Jeffrey, I. Z. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and
Drug delivery. ACS nano. 2008, 2, 889-896.

43

19. Frattini, A.; Pelligri, N.; Nicastro, D.; Sanctis, O. Preparation of amine coated silver
nanoparticles using triethylenetetramine. J. Chem. Sci. 2009, 121, 83–87.
20. Hernandezbattez, A, et al. CuO, ZrO2 and ZnO nanoparticles as antiwear additive in
oil lubricants. 2007, 265, 3-4.
21. Banoee, M, S. S.; Nazari, Z. E.; Jafari, F. P.; Shahverdi, H. R.; Moballegh, A.;
Moghaddam, K. M.; Shahverdi, A. R. ZnO nanoparticles enhanced antibacterial
activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli. Journal
of Biomedical Materials Research. 2010, 93, 557-61.
22. Tian, X.; Michael, K.; Monty, L.; Lutz, M.; Benjamin, G.; Haibin, S.; Joanne, I. Y.;
Jeffrey, I. Z.; Andre, E. N. Comparison of the Mechanism of Toxicity of Zinc Oxide
and Cerium Oxide Nanoparticles Based on Dissolution and Oxidative Stress
Properties. ACS Nano. 2008, 2, 2121-2134.
23. Chai, W. B.; Zhiyong, Z.; Wenjing, Tian.; Xiao, H.; Yuhui, Ma.; Yuliang, Z. Z.
Toxicity of zinc oxide nanoparticles to zebrafish embryo: a physicochemical study of
toxicity mechanism. J Nanopart Res. 2010, 12, 1645–1654.
24. Yuan, Y., et al. TiO2 nanoparticles co-doped with silver and nitrogen for antibacterial
application. Journal of Nanoscience Nanotechnology . 2010, 10, 4868-74. 25.
25. Elvio, A., et al. Synthesis, Characterization and Antibacterial Activity against Gram
Positive and Gram Negative Bactera of biomimetically coated silver nanoparticles.
Langmuir. 2011, 27, 9165–9173.
26. Kim, J. S., et al. Antimicrobial effects of silver nanoparticles. Nanomedicine:
Nanotechnology, Biology, and Medicine. 2007, 3, 95-101.

44

27. Enrique, N.; Flavio, P.; Bettina, W.; Fabio, Marconi.; Ralf.; Kaegi, N. O.; laura, S.
Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii. Environmental
Science and technology. 2008, 42, 23.
28. Martinez, G. A, et al. Synthesis and antibacterial activity of silver nanoparticles with
different sizes. Journal of Nanoparticle Research. 2008, 10, 1343–1348.
29. Sondi, I.; Sondi, B. S. Silver nanoparticles as antimicrobial agent: a case study on E.
coli as a model for Gram-negative bacteria. Journal of Colloid and Interface Science.
2004, 275, 177–182.
30. Meghan, E.; Samberg.; Steven, J.; Oldenburg.; Nancy, A.; Monteiro-Riviere.
Evaluation of Silver Nanoparticle Toxicity in Skin in Vivo and Keratinocytes in vitro.
Environmental Health Perspectives. 2010, 118, 3.
31. Kim, S.; Choi, J. E.; Choi, J.; Chung, K. H.; Park, K.; Yi, J.; Ryu, D. Y. Oxidative
stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Epub.
2009, 1076-1084.
32. AshaRani, P. V.; Yi, L.; Zhiyuan, G.; Suresh, V. Toxicity of silver nanoparticles in
zebrafish models. Nanotechnology , 2008, 19, 8.
33. AshaRani, P. V.; Grace, L. K. M.; Manoor, P. H.; Suresh, V. Cytotoxicity and
Genotoxicity of SilverNanoparticles in Human Cells. American Chemical society
Nano. 2009, 3, 279-290.
34. Astruc, M. D.; Didier. Gold Nanoparticles: Assembly, Supramolecular Chemistry
Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and
Nanotechnology. American Chemical Society. 2004, 104, 293-346.

45

35. Yadav, V. K.; Sudesh, K. Plant-mediated synthesis of silver and gold nanoparticles
and their applications. J Chem Technol Biotechnol. 2009, 84, 151-157.
36. Catherine, J. M.; Anand, M.; Gole, J. W.; Stone, P. N.; Sisco, A. M.; Alkilany. Sarah,
C. B. Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging. Accounts
of chemical Research. 2008, 41, 1721-1730.
37. Khlebtsov, L. D.; Nikolai. Gold nanoparticles in biomedical applications, recent
advances and perspectives. Chem. Soc. Rev. 2012, 41, 2256–2282.
38. Burygin, G. L.; Khlebtsov, B. N.; Shantrokha, A. N.; Dykman, L. A.; Bogatyrev, V.
A.; Khlebtsov, N. G. On the Enhanced Antibacterial Activity of Antibiotics Mixed
with Gold Nanoparticles. Nanoscale Research Letter. 2008, 4, 794–801.
39. Williams, D. A.; Fleming.; Mary, E. Size-Controlled Synthesis of Gold
Nanoparticles via High-Temperature Reduction. Langmuir. 2004, 20, 3021-3023.
40. Zhou, Y.; Wang, C. Y.; Zhu, Y. R.; Chen, Z. Y. A Novel Ultraviolet Irradiation
Technique for Shape-Controlled Synthesis of Gold Nanoparticles at Room
Temperature. Journal of American Chemical Society. 1999, 11, 2310-2312.
41. Yong, S.; Yongdong, J.; Shaojun, D. Synthesis of gold nanoplates by aspartate
reduction of gold chloride. Chemical Communications. 2004, 1104-1105.
42. Aslam, M.; Lei Fu, M.; Vijayamohananb, M.; Vinayak P. D. Novel one-step
synthesis of amine-stabilized aqueous colloidal gold nanoparticles. Journal of
Materials Chemistry. 2004, 14, 1795-1798.
43. Smitha, S. L.; Daizy, P.; Gopchandran, K. G. Green synthesis of gold nanoparticles
using Cinnamomum zeylanicum leaf broth. Elseveir. 2009, 74, 3.

46

44. Umezawa, H. Kanamycin and its discovery. Annals of the New York Academy of
Sciences. 2006, 76.
45. Cron, M. J.; Fardig, O. B.; Johnson, D. L.; Palermiti, F. M.; Schmitz, H.; Hooper, I.
R. The Chemistry of Kanamycin. Annals of the New York Academy of Science. 2006,
76.
46. Gourevitch, V. Z.; Rossomano, J. M.; Tynda, T. A.; Puglisi.; Lein, J. Microbiological
Studies With Kanamycin. Annals of the New York Academy of Sciences. 2006, 76.
47. Vivek, D. B.; Jane, J. B.; Jesse, W. E.; Shivendra, V. S.; Chad, B. W.; Rajalingam,
D. Single-Step Biofriendly Synthesis of Surface Modifiable, Near-Spherical Gold
Nanoparticles for Applications in Biological Detection and Catalysis. Langmuir.
2011, 27, 5549–5554.
48. Treffers, H. P. The linear representation of dosage responsive curves in microbial
antibiotic assays. Journal of bacteriology. 1956, 72, 108.
49. Ncube, N. S.; Afolayan, A. J.; Okoh, A. I. Assessment techniques of antimicrobial
properties of natural compounds of plant origin: current methods and future trends.
African Journal of Biotechnology. 2008, 7, 1797-1806.
50. Carlo, R.; Idlo, N. Analysis of apoptosis by propidium iodide staining and flow
cytometry. Nature protocols. 2006, 1, 3.
51. Lyonad, Delinay.; Alvarez, P. J. Fullerene Water Suspension (nC60) Exerts
Antibacterial Effects via ROS-Independent Protein Oxidation. Environ. Sci. Technol.
2008, 42, 8127-8132.

47

52. Kenneth, H. J.; James, A.S. An Improved Method to Determine Cell Viability by
Simultaneous Staining with Fluorescein Diacetate-Propidium Iodide. The Journal of
Histochemistry and Cytochemistry. 1985, 33, 77-79.
53. Stanley, L. F.; John, W. H.; Karen, L. K. Scanning and Transmission Electron
Microscopy-An introduction. Oxford university press, 1995.
54. Dillon, S. P.; Lakshmisri, M. V.; Vivek, D. B.; Helen, T.; Rammohan, P.;
Rajalingam, D. A New Class of Gold Nanoantibiotics- Direct Coating of Ampicillin
on Gold Nanoparticles. Pharmaceutical Nanotechnology. 2013 ,1, 126-135.
55. Ivan, H. E.; Xiaohua, H.; Mostafa, A. E. Surface Plasmon Resonance Scattering and
Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer
Diagnostics: Applications in Oral Cancer. Nano letters. 2005, 5, 824-839.
56. Satoshiut Sunomiya, G.; Androcynec, E. Application of High-Angle AnnularDark
Field Scanning Transmission Electron Microscopy, Scanning Transmission Electron
Microscopy-Energy Dispersive X-ray Spectrometry, and Energy-Filtered
Transmission Electron Microscopy to the Characterization of nanoparticles. Environ.
Sci. Technol. 2003, 37, 786-791

48

